{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:14:56Z","timestamp":1707524096556},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,9]]},"DOI":"10.7759\/cureus.9093","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T14:35:47Z","timestamp":1594305347000},"source":"Crossref","is-referenced-by-count":0,"title":["Case of Complete Remission After Volumetric Modulated Arc Therapy to Primary Tumor Alone in Locally Advanced Anal Canal Cancer With Active AIDS and Low CD4 Cell Count: Longest Survival in History?"],"prefix":"10.7759","author":[{"given":"Ming","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"The role of radiotherapy in the management of cancer patients infected by human immunodeficiency virus (HIV). (2001). Accessed. June 15, 2020: https:\/\/www-pub.iaea.org\/MTCD\/publications\/PDF\/te_1224_prn.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02052589","article-title":"Squamous-cell carcinoma of the anus in HIV-positive patients","volume":"37","author":"Chadha M","year":"1994","unstructured":"Chadha M, Rosenblatt EA, Malamud S, Pisch J, Berson A. Squamous-cell carcinoma of the anus in HIV-positive patients. Dis Colon Rectum. 1994, 37:861-865. 10.1007\/BF02052589","journal-title":"Dis Colon Rectum"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(97)09028-4","article-title":"Spectrum of AIDS-associated malignant disorders","volume":"351","author":"Goedert JJ","year":"1998","unstructured":"Goedert JJ, Cote TR, Virgo P, et al.. Spectrum of AIDS-associated malignant disorders. Lancet. 1998, 351:1833-1839. 10.1016\/s0140-6736(97)09028-4","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(98)00528-8","article-title":"The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer","volume":"44","author":"Hoffman R","year":"1999","unstructured":"Hoffman R, Welton ML, Klecke B, Weinberg V, Krieg R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys. 1999, 44:127-131. 10.1016\/s0360-3016(98)00528-8","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.193.1.8090901","article-title":"Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy","volume":"193","author":"Holland JM","year":"1994","unstructured":"Holland JM, Swift PS. Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy. Radiology. 1994, 193:251-254. 10.1148\/radiology.193.1.8090901","journal-title":"Radiology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(96)00596-2","article-title":"Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal","volume":"37","author":"Peddada AV","year":"1997","unstructured":"Peddada AV, Smith DE, Rao AR, Frost DB, Kagan AR. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 1997, 37:1101-1105. 10.1016\/s0360-3016(96)00596-2","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/02841869709001360","article-title":"Low acute toxicity of radiotherapy in patients with cancer of the anal canal and HIV-infection","volume":"36","author":"Hocht S","year":"1997","unstructured":"Hocht S, Wiegel T, Kroesen AJ, Berdel WE, Runkel N, Hinkelbein W. Low acute toxicity of radiotherapy in patients with cancer of the anal canal and HIV-infection. Acta Oncol. 1997, 36:799-802. 10.3109\/02841869709001360","journal-title":"Acta Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(97)00329-5","article-title":"Time-dose considerations in the treatment of anal cancer","volume":"39","author":"Constantinou EC","year":"1997","unstructured":"Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, DeLaney TF. Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys. 1997, 39:651-657. 10.1016\/s0360-3016(97)00329-5","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-8049(00)00009-5","article-title":"Treatment of HIV-associated invasive anal cancer with combined chemoradiation","volume":"36","author":"Cleator S","year":"2000","unstructured":"Cleator S, Fife K, Nelson M, Gazzard B, Phillips R, Bower M. Treatment of HIV-associated invasive anal cancer with combined chemoradiation. Eur J Cancer. 2000, 36:754-758. 10.1016\/s0959-8049(00)00009-5","journal-title":"Eur J Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0936-6555(05)80720-4","article-title":"Epidermoid anal cancer in HIV infected patients","volume":"8","author":"Bottomley DM","year":"1996","unstructured":"Bottomley DM, Aqel N, Selvaratnam G, Phillips RH. Epidermoid anal cancer in HIV infected patients. Clin Oncol. 1996, 8:319-322. 10.1016\/s0936-6555(05)80720-4","journal-title":"Clin Oncol"},{"key":"ref11","unstructured":"American Joint Committee on Cancer (AJCC) Cancer Staging Manual Seventh Edition. (2010). Accessed. July 8, 2020: https:\/\/cancerstaging.org\/references-tools\/deskreferences\/Documents\/AJCC%207th%20Ed%20Cancer%20Staging%20Manual.pdf."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200412150-00004","article-title":"HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?","volume":"37","author":"Bower M","year":"2004","unstructured":"Bower M, Powles T, Newsom-Davis T, et al.. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?. J Acquir Immune Defic Syndr. 2004, 37:1563-1565. 10.1097\/00126334-200412150-00004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.5486","article-title":"Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French hospital database on HIV","volume":"30","author":"Piketty C","year":"2012","unstructured":"Piketty C, Selinger-Leneman H, Bouvier AM, et al.. Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French hospital database on HIV. J Clin Oncol. 2012, 30:4360-4366. 10.1200\/JCO.2012.44.5486","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/BF02234605","article-title":"HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients","volume":"44","author":"Kim JH","year":"2001","unstructured":"Kim JH, Sarani B, Orkin BA, et al.. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. Dis Colon Rectum. 2001, 44:1496-1502. 10.1007\/BF02234605","journal-title":"Dis Colon Rectum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr050","article-title":"Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression","volume":"23","author":"Alfa-Wali M","year":"2012","unstructured":"Alfa-Wali M, Allen-Mersh T, Antoniou A, et al.. Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression. Ann Oncol. 2012, 23:141-147. 10.1093\/annonc\/mdr050","journal-title":"Ann Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomized UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover J","year":"2010","unstructured":"Northover J, Glynne-Jones R, Sebag-Montefiore D, et al.. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomized UKCCCR Anal Cancer Trial (ACT I). Br J Cancer. 2010, 102:1123-1128. 10.1038\/sj.bjc.6605605","journal-title":"Br J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A Randomized Controlled Trial","volume":"299","author":"Ajani JA","year":"2008","unstructured":"Ajani JA, Winter KA, Gunderson LL, et al.. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A Randomized Controlled Trial. JAMA. 2008, 299:1914-1921. 10.1001\/jama.299.16.1914","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.253","article-title":"Spectrum of cancer risk late after AIDS onset in the United States","volume":"170","author":"Simard EP","year":"2010","unstructured":"Simard EP, Pfeiffer RM, Engels EA. Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med. 2010, 170:1337-1345. 10.1001\/archinternmed.2010.253","journal-title":"Arch Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09712.x","article-title":"Anal carcinoma in human immunodeficiency virus-positive men: results of a prospective study from Germany","volume":"162","author":"Kreuter A","year":"2010","unstructured":"Kreuter A, Potthoff A, Brockmeyer NH, et al.. Anal carcinoma in human immunodeficiency virus-positive men: results of a prospective study from Germany. Br J Dermatol. 2010, 162:1269-1277. 10.1111\/j.1365-2133.2010.09712.x","journal-title":"Br J Dermatol"},{"key":"ref20","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Anal Carcinoma, Version 2.2020. (2020). Accessed: June 15, 2020: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/anal.pdf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/33263-case-of-complete-remission-after-volumetric-modulated-arc-therapy-to-primary-tumor-alone-in-locally-advanced-anal-canal-cancer-with-active-aids-and-low-cd4-cell-count-longest-survival-in-history","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:44Z","timestamp":1707506864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/33263-case-of-complete-remission-after-volumetric-modulated-arc-therapy-to-primary-tumor-alone-in-locally-advanced-anal-canal-cancer-with-active-aids-and-low-cd4-cell-count-longest-survival-in-history"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.9093","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,9]]}}}